Latest

This mRNA vaccine could potentially prevent the return of the deadliest form of skin cancer

CBS News · August 20, 2026 at 10:02 AM

Drug manufacturers Moderna and Merck say a personalized mRNA cancer vaccine plus a drug called Keytruda reduced the return and spread of melanoma in high-risk patients.

Dr.

Jon LaPook and trial researcher Dr.

Janice Mehnert have more information.

Read the full article on CBS News ›

5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.cbsnews.com — the content belongs to CBS News.

This story in other outlets

New mRNA vaccine could reduce the recurrence and spread of skin cancer

NPR Health · 8 h ago

This mRNA vaccine could potentially prevent the return of the deadliest form of skin cancer

This story in other outlets

New mRNA vaccine could reduce the recurrence and spread of skin cancer

More from CBS News

Iran dismisses Trump's "economic D-Day" threat as more "failed policies"

Police hunt for woman suspected of killing cop husband in Massachusetts

ICE, Iran quietly worked together on deporting Iranians to Iran, emails show

U.S. designates American citizen held by China as wrongfully detained

More in Latest

Dominion still has pending lawsuits against election deniers such as Rudy Giuliani and Sidney Powell

Russia is 'going backwards' in equipment and deploying post WWII-era tanks, according to Western officials

Podcast: One country musician is calling for other artists to oppose assault rifles

Bidets save you money and reduce waste — we tested the best options out there

50+ products to make your life easier and our planet cleaner

Mother's Day is around the corner. Here are 50+ thoughtful gifts she'll love